60. Aplastic anemia Clinical trials / Disease details
Clinical trials : 245 / Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03906318 (ClinicalTrials.gov) | April 3, 2018 | 4/4/2019 | Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia | Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia | Aplastic Anemia | Drug: Iticitinib | Incyte Corporation | NULL | No longer available | N/A | N/A | All | NULL |